Lung Adenocarcinoma Complicated by Hydropneumothorax and Pericardial Effusion with Impending Cardiac Tamponade: A Rare Case Report From A Rural Hospital In Ketapang Regency

english

Authors

DOI:

https://doi.org/10.33533/jpm.v18i2.9259

Keywords:

Adenocarcinoma, Hydropneumothorax and Pericardial Effusion

Abstract

Lung adenocarcinoma is often associated with pulmonary complications such as hydropneumothorax and pleural effusion, and cardiac complications such as cardiac tamponade and pericardial effusion, but are very rare. In our case, a 52-year-old woman presented with worsening shortness of breath for 1 month. The patient underwent thoracentesis after chest X-ray showed right pleural effusion. Pleural fluid cytology showed pulmonary adenocarcinoma. Chest CT scan showed hydropneumothorax and pericardial effusion. In conclusion, pleural effusion is common in lung malignancies. In this case, hydropneumothorax occurred due to repeated thoracentesis of massive pleural effusion. Pericardial effusion is uncommon. This is due to the presence of metastases in the pericardium that obstruct lymphatic drainage, so pericardial fluid analysis is needed.

Author Biographies

Kesih Kalua, Rumah Sakit Umum Daerah Dr. Agoesdjam, Ketapang, Indonesia

General Practitioner

Herick Alvenus Willim, Rumah Sakit Umum Daerah Dr. Agoesdjam, Ketapang, Indonesia

Generap Practitioner

Eva Lydia Munthe, Departemen Pulmonologis, Rumah Sakit Umum Daerah Dr. Agoesdjam, Ketapang, Indonesia

Pulmonologist, Sp.P(K)

References

American Cancer Society. Cancer Facts and Figures 2023. Atlanta; American Cancer Society: 2023.

National Institute of Health. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). 2022.

Asmara OD, Tenda E, Singh G, Ceva, Pitoyo CW, Rumende CM, et al. Lung Cancer in Indonesia. Journal of Thoracic Oncology. 2023;18(9):1134-1145.

Li C, Lu H. Adenosquamous carcinoma of the lung. Onco Targets Ther. 2018;11:4829-4835.

Rami PR, Call S, Dooms C, Obiols C, Sánchez M, Travis WD, et al. Lung cancer staging: a concise update. Eur Respir J. 2018;51(5)

Majmundar N, Shao B, Assina R. Lung adenocarcinoma presenting as intramedullary spinal cord metastasis: Case report and review of literature. J Clin Neurosci. 2018;52:124-131.

Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71: 209–249.

Cheng Y, Wang Q, Li K. Overall survival (OS) update in ALTER 1202: anlotinib as third-line or further-line treatment in relapsed small-cell lung cancer (SCLC). Annals of Oncology 2019; 30: v711

Kolbas I, Evman S, Tezel C. Spontaneous pneumothorax in the elderly: a sign of malignancy? Asian Cardiovasc Thorac Ann 2019; 27: 294–297.

Kort S, Keizer MB, Schouwink H, Citgez E, Jongh F, Putten J, et al. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study. Chest. 2023;163(3):697-706

Si X, Li Z, Wang H. Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: experiences in ALTER-0303. Thorac Cancer 2019;10: 551–556.

Sappington D, Helms S, Siegel E, Penney RB, Jeffus S, Bartter T, et al. Diagnosis of lung tumor types based on metabolomic profiles in lymph node aspirates. Cancer Treat Res Commun. 2018;14:1-6.

Jiang G, Chen C, Zhu Y, Xie D, Dai J, Jin K et al. [Shanghai Pulmonary Hospital Experts Consensus on the Management of Ground-Glass Nodules Suspected as Lung Adenocarcinoma (Version 1)]. Zhongguo. 2018;21(3):147-159.

Paliwal P, Rajappa S, Santa A, Mohan M, Murthy S, Lavanya N, et al. Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience. Indian J Cancer. 2017;54(1):197-202.

Sun YL, Gao F, Gao P, Jin L, Li C, Hua YQ, et al. [Diagnostic value of contrast-enhanced CT scans in identifying lung adenocarcinomas manifesting as ground glass nodules]. Zhonghua Zhong Liu Za Zhi. 2018;40(7):534-538.

Japuntich SJ, Krieger NH, Salvas AL, Carey MP. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation. J Natl Med Assoc. 2018 Oct;110(5):424-427.

Yang S, Yu X, Fan Y, Shi X, Jin Y. Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and KRAS mutation. J Cancer. 2018;9(16):2930-2937.

Jao K, Tomasini P, Kamel-Reid S, Korpanty GJ, Mascaux C, Sakashita S, et al. The prognostic effect of single andmultiple cancer-related somatic mutations in resected non-small-cell lung cancer. Lung Cancer. 2018 Sep;123:22-29.

Imazio, Deerrari G. Cardiac tamponade: an educational review, European Heart Journal. Acute Cardiovascular Care. 2021;10(1):102–109.

He B, Yang Z, Zhao P, Li YJ, Wang JG. Cytopathologic analysis of pericardial effusions in 116 cases: Implications for poor prognosis in lung cancer patients with positive interpretations. Cytopathol Diagn. 2017;45:287–93.

Strobbe A, Adriaenssens T, Bennett J, Dubois C, Desmet W, McCutcheon K, et al. Etiology and long-term outcome of patients undergoing pericardiocentesis. J Am Heart Assoc. 2027;6:e007598.

Rolof GP, Damhuis R, Wekken A, Hendrik L, Groen H, Geffen W et al. Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study. The Lancet Regional Health – Europe. 2023;27: 100592.

Downloads

Published

2024-12-31

How to Cite

Saputra, G. A., Kalua, K., Willim, H. A., & Munthe, E. L. (2024). Lung Adenocarcinoma Complicated by Hydropneumothorax and Pericardial Effusion with Impending Cardiac Tamponade: A Rare Case Report From A Rural Hospital In Ketapang Regency: english. Jurnal Profesi Medika : Jurnal Kedokteran Dan Kesehatan, 18(2), 243–251. https://doi.org/10.33533/jpm.v18i2.9259

Issue

Vol. 18 No. 2 (2024): Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan

Section

Case Study

Categories

License

Copyright (c) 2024 Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright Notice

All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher

Note :

The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.

Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).